Clinical Research Directory
Browse clinical research sites, groups, and studies.
Fibrosis Assessment in Myocardial Infarction-associated Ventricular Aneurysm
Sponsor: RenJi Hospital
Summary
The study will use 18F-FAPI PET/CT to study myocardial fibrosis in patients diagnosed with myocardial infarction-associated ventricular aneurysm (MI-VA). Participants will receive the PET/CT scan during hospital stay, as well as serial echocardiography and telephonic follow-ups. Analysed will focus on the characterization of myocardial fibrosis and its correlations with the clinical prognosis in the patients.
Official title: Assessment of Myocardial Fibrosis by 18F-FAPI/PET-CT in Patients With Myocardial Infarction-associated Ventricular Aneurysm
Key Details
Gender
All
Age Range
18 Years - 75 Years
Study Type
OBSERVATIONAL
Enrollment
20
Start Date
2024-11-01
Completion Date
2025-12-31
Last Updated
2025-05-29
Healthy Volunteers
Not specified
Conditions
Interventions
18F FAPI-42 PET/CT scan
During the hospital stay, participants will receive an 18F FAPI-42 PET/CT scan. 18F FAPI-42 is a new fibroblast activation protein (FAP)-specific tracer used for fibrosis imaging. PET/CT will be performed using the ultra-high-resolution digital PET/CT uEXPLORER (United Imaging, Shanghai, China)
Locations (1)
Renji Hospital
Shanghai, China